Suchergebnisse - "Rimassa, Lorenza"

PubPharm (17)

1

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

2

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01) : a multicentre, single-arm, phase 2b study

enthalten in: The Lancet. Oncology | 2023

von Harding, J. | Fan, J. | Oh, D. | +61

3

Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma

enthalten in: Clinical drug investigation | 2021

von Ryoo, B. | Palmer, D. | Park, S. | +6

ErratumIn: Clin Drug Investig. 2022 Mar;42(3):283. - PMID 35220556

4

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy : A pre-specified secondary analysis of the Valentino study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Raimondi, A. | Di Maio, M. | Morano, F. | +24

5

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Pietrantonio, F. | Lobefaro, R. | Antista, M. | +28

CommentIn: Clin Cancer Res. 2020 Jul 1;26(13):3493-3494. - PMID 32611627

6

Regorafenib in patients with refractory metastatic pancreatic cancer : a Phase II study (RESOUND)

enthalten in: Future oncology (London, England) | 2019

von Bozzarelli, S. | Rimassa, L. | Giordano, L. | +8

7

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Morano, F. | Corallo, S. | Lonardi, S. | +22

CommentIn: J Clin Oncol. 2019 Nov 20;37(33):3066-3068. - PMID 31550189

8

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression : Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

enthalten in: Clinical colorectal cancer | 2019

von Rimassa, L. | Bozzarelli, S. | Pietrantonio, F. | +14

9

Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15) : a randomised, open-label, phase 2-3 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2018

von Reni, M. | Balzano, G. | Zanon, S. | +14

CommentIn: Lancet Gastroenterol Hepatol. 2018 Jun;3(6):375-376. - PMID 29625842

10

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

enthalten in: Oncotarget | 2016

von Rimassa, L. | Abbadessa, G. | Personeni, N. | +17